SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Adaptive Biotechnologies COO Julie Rubinstein Reports $897,456.68 Share Sale

President and COO Julie Rubinstein reports selling $897,456.68 in common shares.

ADPT

Related stories